An emerging generation of endocrine therapies in breast cancer: a clinical perspective

IJMS, Free Full-Text

Therapeutic resistance to anti-oestrogen therapy in breast cancer

Randomized Phase II Trial of Fulvestrant Plus Everolimus or

Emerging Concepts in the Management of Breast Cancer: Perspectives From Chicago (Transcript)

B cells in tumor metastasis: friend or foe?

Advancements in clinical aspects of targeted therapy and

Navigating the cellular landscape in tissue: Recent advances in

CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1

Endocrine therapy in metastatic breast cancer-more than just CDK4/6 inhibitors